ALIM Alimera Sciences Inc

Alimera Sciences Inc is a biopharmaceutical company which is engaged in the research, development, and commercialization of ophthalmic pharmaceuticals.

As of 05/25/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  04/22/2010
Outstanding shares:  7,002,961
Average volume:  27,341
Market cap:   $37,815,989
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   -6.19
PB ratio:   -12.32
PS ratio:   0.63
Return on equity:   77.64%
Net income %:   -11.19%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy